Identification of survival‐related genes of the phosphatidylinositol 3′‐kinase signaling pathway in glioblastoma multiforme

Knowledge of the molecular mechanisms involved in the biology of glioblastoma multiforme (GBM) is essential for the identification of candidate prognostic markers, new putative therapeutic targets, and early detection strategies predictive of survival.

[1]  Linet,et al.  RESPONSE: Re: Brain and Other Central Nervous System Cancers: Recent Trends in Incidence and Mortality. , 1999, Journal of the National Cancer Institute.

[2]  A. Dopazo,et al.  Identification of genes involved in resistance to interferon-alpha in cutaneous T-cell lymphoma. , 2002, The American journal of pathology.

[3]  L. Qin,et al.  Empirical evaluation of data transformations and ranking statistics for microarray analysis. , 2004, Nucleic acids research.

[4]  Y. Benjamini,et al.  Controlling the false discovery rate in behavior genetics research , 2001, Behavioural Brain Research.

[5]  E. Campo,et al.  Splenic marginal zone lymphoma: proposal of new diagnostic and prognostic markers identified after tissue and cDNA microarray analysis. , 2005, Blood.

[6]  M. Brada.  Pathology and Genetics of Tumours of the Nervous System , 2001, British Journal of Cancer.

[7]  Li Zhang,et al.  Prognostic Associations of Activated Mitogen-Activated Protein Kinase and Akt Pathways in Glioblastoma , 2006, Clinical Cancer Research.

[8]  P. Cartron,et al.  The expression of a new variant of the pro-apoptotic molecule Bax, Baxpsi, is correlated with an increased survival of glioblastoma multiforme patients. , 2002, Human molecular genetics.

[9]  Juan F. García,et al.  Variability in the Degree of Expression of Phosphorylated IκBα in Chronic Lymphocytic Leukemia Cases With Nodal Involvement , 2004, Clinical Cancer Research.

[10]  P. Cohen,et al.  Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B , 1995, Nature.

[11]  Paul S Mischel,et al.  Identification of molecular subtypes of glioblastoma by gene expression profiling , 2003, Oncogene.

[12]  Dejan Juric,et al.  Functional network analysis reveals extended gliomagenesis pathway maps and three novel MYC-interacting genes in human gliomas. , 2005, Cancer research.

[13]  Juan F. García,et al.  Variability in the degree of expression of phosphorylated IkappaBalpha in chronic lymphocytic leukemia cases with nodal involvement. , 2004, Clinical cancer research : an official journal of the American Association for Cancer Research.

[14]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[15]  D. Louis,et al.  AKT activation in human glioblastomas enhances proliferation via TSC2 and S6 kinase signaling. , 2006, Cancer research.

[16]  Joaquín Dopazo,et al.  DNMAD: web-based diagnosis and normalization for microarray data , 2004, Bioinform..

[17]  K. Aldape,et al.  Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma. , 2005, Cancer research.

[18]  K. Nishio,et al.  Identification of expressed genes characterizing long-term survival in malignant glioma patients , 2006, Oncogene.

[19]  P. Kleihues,et al.  Primary and secondary glioblastomas: from concept to clinical diagnosis. , 1999, Neuro-oncology.

[20]  D. Bigner,et al.  Development of novel targeted therapies in the treatment of malignant glioma , 2004, Nature Reviews Drug Discovery.

[21]  Shili Duan,et al.  Molecular recognition of p53 and MDM2 by USP7/HAUSP , 2006, Nature Structural &Molecular Biology.

[22]  Jayant P. Menon,et al.  Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. , 2006, Cancer cell.

[23]  A. Dopazo,et al.  Identification of genes involved in resistance to interferon-alpha in cutaneous T-cell lymphoma. , 2002, The American journal of pathology.

[24]  W. Whetsell,et al.  Lipocortin-1 immunoreactivity in central and peripheral nervous system glial tumors. , 1989, Human pathology.

[25]  Joaquín Dopazo,et al.  Gene expression data preprocessing , 2003, Bioinform..

[26]  Tanja Woyke,et al.  Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets. , 2005, Neoplasia.

[27]  R. Pepinsky.  Phosphorylation of lipocortin-1 by the epidermal growth factor receptor. , 1991, Methods in enzymology.

[28]  Linet,et al.  RESPONSE: re: brain and other central nervous system cancers: recent trends in incidence and mortality , 1999, Journal of the National Cancer Institute.

[29]  James V. Leonard,et al.  [Primary central nervous system lymphomas]. , 2010, Vnitrni lekarstvi.

[30]  N. Chang,et al.  TIAF1 Participates in the Transforming Growth Factor β1‐Mediated Growth Regulation , 2003, Annals of the New York Academy of Sciences.

[31]  Nan-Shan Chang,et al.  TIAF1 and p53 functionally interact in mediating apoptosis and silencing of TIAF1 abolishes nuclear translocation of serine 15-phosphorylated p53. , 2004, DNA and cell biology.

[32]  M. Westphal,et al.  Cost of migration: invasion of malignant gliomas and implications for treatment. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  Joaquín Dopazo,et al.  FatiGO: a web tool for finding significant associations of Gene Ontology terms with groups of genes , 2004, Bioinform..

[34]  D. Botstein,et al.  Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[35]  M. Berger,et al.  Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib. , 2005, Journal of the National Cancer Institute.

[36]  Ryan M. Anderson,et al.  Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway. , 2004, Cancer cell.

[37]  Y. Yonekawa,et al.  Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. , 1996, Brain pathology.

[38]  J. Cigudosa,et al.  Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[39]  C. Sawyers,et al.  The phosphatidylinositol 3-Kinase–AKT pathway in human cancer , 2002, Nature Reviews Cancer.

[40]  H. Sasaki,et al.  Expression of the periostin mRNA level in neuroblastoma. , 2002, Journal of pediatric surgery.

[41]  Optical coherence tomography: an assessment of current training across all levels of seniority in 8 ophthalmic units in the united kingdom , 2006, BMC ophthalmology.

[42]  M. Roussel,et al.  Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. , 1998, Genes & development.

[43]  Paul S Mischel,et al.  Gene expression profiling identifies molecular subtypes of gliomas , 2003, Oncogene.

[44]  Pepinsky Rb.  Phosphorylation of lipocortin-1 by the epidermal growth factor receptor. , 1991 .

[45]  W. Sellers,et al.  The PTEN tumor suppressor protein: an antagonist of phosphoinositide 3-kinase signaling. , 2000, Biochimica et biophysica acta.

[46]  Dong Xie,et al.  Cyr61 Is Overexpressed in Gliomas and Involved in Integrin-Linked Kinase-Mediated Akt and β-Catenin-TCF/Lef Signaling Pathways , 2004, Cancer Research.

[47]  Quan-hong Wang,et al.  Quantitative real-time RT-PCR validation of differential mRNA expression of SPARC, FADD, Fascin, COL7A1, CK4, TGM3, ECM1, PPL and EVPL in esophageal squamous cell carcinoma , 2006, BMC Cancer.

[48]  S. Dudoit,et al.  Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. , 2002, Nucleic acids research.

[49]  Y. Shiloh,et al.  ATM-Mediated Phosphorylations Inhibit Mdmx/Mdm2 Stabilization by HAUSP in Favor of p53 Activation , 2005, Cell cycle.

[50]  D. Pranys,et al.  Impact of morphology and biology on the prognosis of patients with gliomas. , 2004, Medicina.